Eurofins Scientific shares surged on Monday on the Paris Stock Exchange, with the bio-analysis specialist posting by far the strongest gain on the CAC 40 after Exane BNP Paribas sharply upgraded its rating on the stock, moving directly from "underperform" to "outperform" and raising its price target to 75 euros.
In a research note, the brokerage firm believes that the French group specializing in testing, inspection, and certification services is at a turning point that should finally allow it to generate growth and cash flow after many years of investment.
Exane considers that the company is now entering an "ideal" phase expected to be marked by an acceleration in growth, highlighting that Eurofins could reach, or even slightly surpass, its target of a 24% adjusted operating (Ebitda) margin by 2027.
From the research firm's perspective, the peak in capital expenditures is now behind the company, which should allow free cash flow (FCF) generation—a factor that has historically concerned investors—to improve from now on.
Around 11:30 a.m., the stock jumped 6.1%, returning to levels close to its highest in over a year on heavy trading volumes, while at the same time, the CAC 40 index was down about 0.1%.
Copyright (c) 2025 Zonebourse.com - All rights reserved.
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products.
At the end of 2024, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 950 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (51%), North America (38.3%) and other (10.7%).
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
